JP Morgan Maintains Neutral on Inspire Medical Systems, Lowers Price Target to $54

Benzinga Newsdesk www.benzinga.com Negative 80.6%

Neg 80.6% Neu 0% Pos 0%

JP Morgan analyst Robbie Marcus maintains Inspire Medical Systems (NYSE:INSP) with a Neutral and lowers the price target from $67 to $54.